+Search query
-Structure paper
Title | Biomolecular Recognition of the Glycan Neoantigen CA19-9 by Distinct Antibodies. |
---|---|
Journal, issue, pages | J. Mol. Biol., Vol. 433, Page 167099-167099, Year 2021 |
Publish date | Jan 16, 2020 (structure data deposition date) |
Authors | Borenstein-Katz, A. / Warszawski, S. / Amon, R. / Eilon, M. / Cohen-Dvashi, H. / Leviatan Ben-Arye, S. / Tasnima, N. / Yu, H. / Chen, X. / Padler-Karavani, V. ...Borenstein-Katz, A. / Warszawski, S. / Amon, R. / Eilon, M. / Cohen-Dvashi, H. / Leviatan Ben-Arye, S. / Tasnima, N. / Yu, H. / Chen, X. / Padler-Karavani, V. / Fleishman, S.J. / Diskin, R. |
External links | J. Mol. Biol. / PubMed:34119488 |
Methods | X-ray diffraction |
Resolution | 1.42 - 2.41 Å |
Structure data | PDB-6xtg: PDB-6xud: PDB-6xuk: PDB-6xul: PDB-6xun: |
Chemicals | ChemComp-NA: ChemComp-HOH: ChemComp-GOL: |
Source |
|
Keywords | ANTITUMOR PROTEIN / Pancreatic cancer / CA19-9 binder / Diagnosis / Immunotherapy reagent / in-silico optimized antibody / immunotherapeutic reagent / Immunotheraeutic agent |